Nuveen Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,833,364
| Closed | -$2.51M | – | 3169 |
|
|
2022
Q4 | $2.51M | Buy |
2,833,364
+729,384
| +35% | +$646K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $3.3M | Buy |
2,103,980
+556,799
| +36% | +$874K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $3.11M | Buy |
1,547,181
+522,509
| +51% | +$1.05M | ﹤0.01% | 2209 |
|
|
2022
Q1 | $2.57M | Buy |
1,024,672
+78,729
| +8% | +$198K | ﹤0.01% | 2388 |
|
|
2021
Q4 | $5.66M | Sell |
945,943
-144,002
| -13% | -$861K | ﹤0.01% | 2043 |
|
|
2021
Q3 | $8.99M | Sell |
1,089,945
-125,802
| -10% | -$1.04M | ﹤0.01% | 1855 |
|
|
2021
Q2 | $11.8M | Buy |
1,215,747
+113,284
| +10% | +$1.1M | ﹤0.01% | 1758 |
|
|
2021
Q1 | $9.12M | Sell |
1,102,463
-173,671
| -14% | -$1.44M | ﹤0.01% | 1854 |
|
|
2020
Q4 | $8.71M | Buy |
1,276,134
+60,315
| +5% | +$412K | ﹤0.01% | 1797 |
|
|
2020
Q3 | $13.6M | Buy |
1,215,819
+390,089
| +47% | +$4.35M | 0.01% | 1310 |
|
|
2020
Q2 | $5.19M | Buy |
825,730
+312,194
| +61% | +$1.96M | ﹤0.01% | 1876 |
|
|
2020
Q1 | $945K | Buy |
513,536
+16,212
| +3% | +$29.8K | ﹤0.01% | 2533 |
|
|
2019
Q4 | $1.68M | Sell |
497,324
-44,864
| -8% | -$152K | ﹤0.01% | 2495 |
|
|
2019
Q3 | $1.16M | Buy |
542,188
+93,448
| +21% | +$200K | ﹤0.01% | 2636 |
|
|
2019
Q2 | $1.2M | Buy |
+448,740
| New | +$1.2M | ﹤0.01% | 2662 |
|